0,633  0,006  Apoptosis antagonist
0,572  0,009  FMO1 substrate
0,564  0,012  GABA C receptor rho-3 antagonist
0,543  0,018  Analeptic
0,462  0,005  Pneumotoxic
0,478  0,024  Antipsoriatic
0,457  0,008  FMO3 substrate
0,479  0,037  Atherosclerosis treatment
0,440  0,004  Aldehyde oxidase substrate
0,473  0,039  Histamine release inhibitor
0,467  0,051  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,410  0,015  Flavin-containing monooxygenase substrate
0,404  0,010  Cytidine deaminase inhibitor
0,413  0,035  Nootropic
0,388  0,016  5 Hydroxytryptamine uptake stimulant
0,368  0,003  Antiprotozoal (Babesia)
0,393  0,030  Radiosensitizer
0,433  0,077  Alzheimer's disease treatment
0,416  0,068  5 Hydroxytryptamine release inhibitor
0,435  0,091  Caspase 9 stimulant
0,387  0,047  Respiratory analeptic
0,388  0,048  Hepatic disorders treatment
0,388  0,055  Inflammatory Bowel disease treatment
0,404  0,075  Antibacterial
0,384  0,073  GST A substrate
0,344  0,042  Antipyretic
0,369  0,073  Ulceration
0,339  0,044  DNA damaging
0,296  0,010  Cell wall synthesis inhibitor
0,300  0,016  Alpha-N-acetylglucosaminidase inhibitor
0,343  0,067  Cholesterol antagonist
0,305  0,031  RNA-directed DNA polymerase inhibitor
0,283  0,009  Ferrochelatase inhibitor
0,334  0,060  5 Hydroxytryptamine release stimulant
0,297  0,038  Peroxidase inhibitor
0,296  0,037  Antiparkinsonian, rigidity relieving
0,304  0,045  GST M1-1 substrate
0,310  0,057  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,278  0,031  Antialcoholic
0,311  0,066  CTGF expression inhibitor
0,257  0,015  DNA intercalator
0,326  0,084  Vasodilator, peripheral
0,282  0,043  Tyrosine 3 hydroxylase inhibitor
0,301  0,066  Aldehyde oxidase inhibitor
0,279  0,046  5 Hydroxytryptamine 1E antagonist
0,244  0,013  Antismoking
0,286  0,058  Hypoglycemic
0,278  0,052  DNA synthesis inhibitor
0,240  0,014  GABA C receptor agonist
0,283  0,058  Cardiovascular analeptic
0,304  0,079  CYP2D6 substrate
0,236  0,015  GABA C receptor rho-2 antagonist
0,282  0,063  Amyotrophic lateral sclerosis treatment
0,305  0,087  Calcium channel activator
0,273  0,062  Sensitization
0,258  0,056  Psychostimulant
0,265  0,063  Angiogenesis stimulant
0,234  0,033  Antiacne
0,274  0,074  UGT2B4 substrate
0,255  0,058  Antiulcerative
0,208  0,012  NAT2 substrate
0,279  0,091  Caspase 3 stimulant
0,213  0,027  Antianemic
0,256  0,071  Superoxide dismutase inhibitor
0,223  0,040  3C-like protease (Human coronavirus) inhibitor
0,266  0,083  Radioprotector
0,191  0,009  Electrolyte absorption antagonist
0,194  0,013  Porphobilinogen synthase inhibitor
0,183  0,002  Antidote, organophosphates
0,204  0,024  Chelator
0,235  0,056  Sedative
0,185  0,006  Antiprotozoal activity enhancer
0,185  0,009  CYP2A6 inhibitor
0,211  0,036  Antiseptic
0,206  0,031  Phobic disorders treatment
0,213  0,038  Muscular dystrophy treatment
0,210  0,035  Neuropathy treatment
0,206  0,031  Carcinogenic, group 1
0,182  0,007  Antidote, mercury
0,279  0,106  Vasodilator, coronary
0,198  0,025  Cystathionine beta-synthase inhibitor
0,203  0,031  Renal failure treatment
0,213  0,043  Acaricide
0,243  0,073  Vasodilator
0,223  0,056  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,208  0,042  Succinate dehydrogenase inhibitor
0,180  0,015  Acetylcholine nicotinic antagonist
0,174  0,010  Ca2+-transporting ATPase inhibitor
0,200  0,037  UGT2B10 substrate
0,185  0,024  Excitatory amino acid transporter EAAC1 inhibitor
0,244  0,086  Gastrin inhibitor
0,252  0,095  Insulysin inhibitor
0,172  0,016  Heat shock protein 70 antagonist
0,218  0,062  Nitric-oxide synthase stimulant
0,217  0,062  Mutagenic
0,197  0,043  Antirickettsial
0,206  0,053  5 Hydroxytryptamine 3E antagonist
0,277  0,125  CYP2C9 substrate
0,308  0,156  Cyclophilin D inhibitor
0,308  0,156  Antidiabetic
0,245  0,093  Spasmolytic
0,195  0,045  Antiparkinsonian, tremor relieving
0,286  0,139  Analgesic, non-opioid
0,175  0,031  Antibacterial (Helicobacter pylori)
0,191  0,048  Cystic fibrosis treatment
0,188  0,046  NOS3 expression enhancer
0,259  0,117  ICAM1 expression inhibitor
0,198  0,056  Prostatic (benign) hyperplasia treatment
0,149  0,010  Tourette's syndrome treatment
0,232  0,094  UGT1A9 substrate
0,196  0,059  UGT1A4 substrate
0,327  0,191  Antiinflammatory
0,183  0,048  Antidote
0,196  0,062  VEGF expression inhibitor
0,211  0,078  Fibrosis treatment
0,152  0,020  GABA C receptor rho-1 antagonist
0,170  0,040  Movement disorders treatment
0,196  0,067  Hepatoprotectant
0,212  0,085  Cyclic AMP phosphodiesterase inhibitor
0,249  0,122  Antihypertensive
0,146  0,019  Acetylcholine release stimulant
0,211  0,085  UGT1A6 substrate
0,227  0,102  Antineoplastic (bladder cancer)
0,212  0,088  Teratogen
0,148  0,024  Myasthenia Gravis treatment
0,146  0,023  Carcinogenic, group 2A
0,172  0,049  Raynaud's phenomenon treatment
0,180  0,058  Prostate disorders treatment
0,150  0,029  UDP-glucose 4-epimerase inhibitor
0,193  0,073  Carcinogenic
0,212  0,092  Antiviral (West Nile virus)
0,123  0,004  Glutamate (mGluR7) antagonist
0,153  0,035  Antiviral (Poxvirus)
0,193  0,077  Abortion inducer
0,158  0,043  Antiprotozoal (Trichomonas)
0,144  0,029  Sphingosine 1-phosphate receptor 2 agonist
0,129  0,014  Nicotinic alpha4beta2 receptor antagonist
0,128  0,013  HIV-1 integrase inhibitor
0,142  0,028  Catalase inhibitor
0,141  0,028  Creatine kinase inhibitor
0,156  0,043  Alkylator
0,141  0,029  Antifungal (Pneumocystis)
0,274  0,162  Analgesic
0,246  0,135  CYP3A4 substrate
0,261  0,152  Antipruritic, allergic
0,138  0,030  HIV-1 integrase (Overall Integration) inhibitor
0,241  0,133  Antithrombotic
0,136  0,029  Prolactin inhibitor
0,121  0,014  Alcohol oxidase inhibitor
0,120  0,014  D-Ala-D-Ala ligase inhibitor
0,125  0,020  Bromodomain-containing protein 2 inhibitor
0,162  0,056  Toll-Like receptor 9 antagonist
0,140  0,036  GABA C receptor antagonist
0,196  0,093  Embryotoxic
0,218  0,115  Antineurogenic pain
0,117  0,014  Biliverdin reductase inhibitor
0,286  0,183  Apoptosis agonist
0,139  0,038  Protein kinase C gamma inhibitor
0,203  0,103  Antihypercholesterolemic
0,211  0,111  Interleukin agonist
0,109  0,009  Antiviral (Parainfluenza)
0,184  0,084  Anesthetic general
0,203  0,104  Antineoplastic (liver cancer)
0,104  0,005  Nicotinic acid receptor agonist
0,106  0,007  Aconitate hydratase inhibitor
0,129  0,030  GST T1-1 substrate
0,146  0,048  Antitussive
0,116  0,019  Neuronal nicotinic receptor antagonist
0,126  0,029  Antispirochetal
0,156  0,059  Hearing loss treatment
0,160  0,063  Hair growth stimulant
0,222  0,126  CYP1A2 substrate
0,161  0,066  UGT2B9 substrate
0,124  0,030  Triose-phosphate isomerase inhibitor
0,124  0,032  Alcohol dehydrogenase inhibitor
0,129  0,037  Adenylate kinase inhibitor
0,138  0,046  Antiviral (Papilloma)
0,130  0,039  Antineoplastic, alkylator
0,096  0,005  Ryanodine receptor antagonist
0,199  0,108  Heart failure treatment
0,201  0,109  Vascular (periferal) disease treatment
0,135  0,044  Falcipain 3 inhibitor
0,096  0,006  Nicotinic acid receptor 2 agonist
0,182  0,093  Insulin sensitizer
0,104  0,015  Antidote, heavy metal
0,167  0,078  Macular degeneration treatment
0,154  0,066  Lipid peroxidase inhibitor
0,109  0,023  NAT1 substrate
0,161  0,076  Arachidonic acid antagonist
0,102  0,017  DNA gyrase inhibitor
0,151  0,068  UGT2B15 substrate
0,119  0,036  Interleukin 1 beta converting enzyme inhibitor
0,130  0,048  5 Hydroxytryptamine 3A agonist
0,134  0,053  Autism spectrum disorders treatment
0,191  0,109  Cytostatic
0,148  0,067  Skeletal muscle relaxant
0,139  0,058  Antihyperlipoproteinemic
0,099  0,019  Bulimia treatment
0,133  0,053  Retinopathy treatment
0,104  0,024  Caspase 7 inhibitor
0,093  0,014  Prostaglandin F2 alpha antagonist
0,085  0,007  Glutamate (mGluR group III) antagonist
0,091  0,014  Nicotinic receptor alpha7 subunit antagonist
0,111  0,034  NADH dehydrogenase inhibitor
0,112  0,036  Histamine N-methyltransferase inhibitor
0,152  0,076  Diuretic
0,115  0,039  MAP kinase kinase 1 inhibitor
0,151  0,075  Cholinergic
0,088  0,013  Plasminogen activator inhibitor antagonist
0,131  0,057  Antiprotozoal (Amoeba)
0,134  0,062  Cholinergic antagonist
0,142  0,070  Pregnane X receptor agonist
0,169  0,097  UGT1A1 substrate
0,132  0,060  Aldehyde dehydrogenase inhibitor
0,131  0,059  Gastritis treatment
0,119  0,048  Mental retardation treatment
0,076  0,004  Nerve growth factor antagonist
0,129  0,058  Beta amyloid protein antagonist
0,114  0,043  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,117  0,047  Antiviral (SARS coronavirus)
0,117  0,047  Antiviral (Coronavirus)
0,162  0,092  Diabetic nephropathy treatment
0,117  0,048  Butyrylcholinesterase inhibitor
0,100  0,033  Telomerase inhibitor
0,097  0,030  Histone deacetylase stimulant
0,097  0,030  Histone deacetylase SIRT1 stimulant
0,160  0,092  Lipocortins synthesis antagonist
0,157  0,090  Catenin beta inhibitor
0,145  0,079  Acetylcholine M1 receptor antagonist
0,158  0,091  Antipruritic, non-allergic
0,155  0,089  Neurotensin receptor agonist
0,100  0,034  Antibiotic
0,168  0,102  CYP2B6 inhibitor
0,103  0,038  Glutamate release inhibitor
0,100  0,034  Granulocyte macrophage colony stimulating factor agonist
0,250  0,184  Antiparkinsonian
0,170  0,104  MAP kinase kinase 2 inhibitor
0,143  0,079  Antimutagenic
0,132  0,070  Toll-Like receptor antagonist
0,081  0,020  Antihemophilic
0,149  0,087  Uterine stimulant
0,126  0,065  Acetylcholine antagonist
0,069  0,008  Geranyltranstransferase inhibitor
0,130  0,069  Acetylcholinesterase inhibitor
0,092  0,032  Narcotic antagonist
0,090  0,031  Phenylalanine 4-hydroxylase inhibitor
0,085  0,026  5 Hydroxytryptamine 3A antagonist
0,102  0,043  Polo-like kinase-1 inhibitor
0,093  0,034  Glutamate decarboxylase inhibitor
0,093  0,035  Glutamate dehydrogenase inhibitor
0,139  0,081  Genotoxic
0,064  0,007  Vesicle monoamine transporter inhibitor
0,066  0,009  GABA B receptor antagonist
0,103  0,046  Antiviral (Rhinovirus)
0,156  0,099  Toxic, respiratory center
0,096  0,040  NAD(P)H dehydrogenase (quinone) inhibitor
0,241  0,185  Antineoplastic (myeloid leukemia)
0,174  0,118  Aryl hydrocarbon receptor agonist
0,139  0,084  Adenylate cyclase stimulant
0,111  0,057  DOPA decarboxylase inhibitor
0,091  0,038  Estrogen-related receptor beta agonist
0,076  0,022  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,079  0,027  5 Hydroxytryptamine 3 agonist
0,087  0,036  Aminopeptidase I inhibitor
0,193  0,142  Chemoprotective
0,063  0,013  Dopamine beta hydroxylase inhibitor
0,216  0,166  Sodium/bile acid cotransporter inhibitor
0,063  0,013  Glutamate (mGluR4) antagonist
0,147  0,098  Antipruritic
0,087  0,037  Phosphofructokinase-1 inhibitor
0,163  0,114  Antihypertriglyceridemic
0,072  0,023  Prostaglandin E2 antagonist
0,074  0,027  Antimycoplasmal
0,086  0,039  Histidine decarboxylase inhibitor
0,164  0,118  Neurotrophic factor enhancer
0,115  0,070  Transcription factor STAT6 inhibitor
0,071  0,026  Acyl-CoA dehydrogenase inhibitor
0,063  0,019  Adenosine deaminase inhibitor
0,109  0,065  Mucolytic
0,056  0,013  Alpha 1d adrenoreceptor agonist
0,155  0,111  Pyruvate kinase inhibitor
0,115  0,072  Antineoplastic antimetabolite
0,091  0,048  Arylamine N-Acetyltransferase substrate
0,098  0,055  Phosphodiesterase 6D inhibitor
0,065  0,022  Pregnane X receptor antagonist
0,085  0,042  Keratolytic
0,136  0,093  Thrombolytic
0,166  0,123  Antiglaucomic
0,063  0,021  5 Hydroxytryptamine 4 antagonist
0,064  0,022  Nicotinic alpha3beta2 receptor antagonist
0,064  0,022  Thromboxane synthase inhibitor
0,052  0,010  Antiviral (Bovine viral diarrhea virus)
0,103  0,062  Gastric antisecretory
0,104  0,063  Aminopeptidase B inhibitor
0,070  0,029  Cyclin D1 inhibitor
0,127  0,086  Protein kinase stimulant
0,192  0,152  Antihypoxic
0,121  0,081  Anesthetic
0,162  0,123  Histone acetyltransferase inhibitor
0,099  0,060  UGT2B11 substrate
0,076  0,037  Protein kinase C beta inhibitor
0,106  0,067  Antihelmintic (Fasciola)
0,158  0,119  Platelet aggregation inhibitor
0,078  0,039  Amidase inhibitor
0,127  0,089  Mannose-6-phosphate isomerase inhibitor
0,088  0,050  Histamine H1 receptor antagonist
0,091  0,055  Ornithine decarboxylase inhibitor
0,050  0,015  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,110  0,074  Microtubule formation inhibitor
0,073  0,038  SULT2A1 substrate
0,051  0,016  Angiotensin AT1 receptor antagonist
0,076  0,041  Peroxisome proliferator-activated receptor gamma antagonist
0,216  0,183  Cognition disorders treatment
0,074  0,041  Leukotriene synthesis inhibitor
0,144  0,111  DNA methyltransferase I inhibitor
0,113  0,082  Antiviral (Influenza B)
0,131  0,100  UGT1A3 substrate
0,175  0,145  Antihypotensive
0,131  0,102  UGT2B7 substrate
0,117  0,088  Antihelmintic (Trematoda)
0,062  0,034  5 Hydroxytryptamine 3 antagonist
0,046  0,018  Kainate receptor agonist
0,133  0,105  Muscle relaxant
0,118  0,090  Cocaine dependence treatment
0,083  0,056  Glutathione S-transferase inhibitor
0,134  0,106  Heat shock protein 90 alpha antagonist
0,051  0,024  Benzodiazepine antagonist
0,125  0,098  SULT1A3 substrate
0,065  0,038  Carbamoyl phosphate synthetase inhibitor
0,095  0,069  Anabolic
0,044  0,018  5 Hydroxytryptamine 3B antagonist
0,088  0,063  GST P1-1 substrate
0,172  0,148  Lipoprotein disorders treatment
0,047  0,023  Histamine H1 receptor agonist
0,165  0,141  VCAM1 expression inhibitor
0,032  0,008  Geranylgeranyltransferase inhibitor
0,215  0,191  TNF expression inhibitor
0,043  0,020  Kainate receptor 2 antagonist
0,151  0,128  Anticonvulsant
0,084  0,061  Acetylcholine agonist
0,107  0,084  MAO inhibitor
0,104  0,082  Cholesterol synthesis inhibitor
0,029  0,006  Antibiotic Quinolone-like
0,101  0,078  SULT1A1 substrate
0,043  0,021  TRPM8 blocker
0,059  0,037  Argininosuccinate synthase inhibitor
0,127  0,105  Phospholipase A2 inhibitor
0,038  0,017  Angiotensin II receptor antagonist
0,042  0,021  Retinoid X receptor antagonist
0,048  0,028  Antiviral (Enterovirus)
0,122  0,103  Chemopreventive
0,076  0,057  Glutamate receptor agonist
0,130  0,111  Interferon gamma antagonist
0,045  0,025  Kainate receptor antagonist
0,086  0,066  Actinic keratosis treatment
0,034  0,015  Nicotinic alpha3beta4 receptor agonist
0,048  0,028  Phosphate transporter inhibitor
0,050  0,031  Antiviral (Herpesvirus 3, Human)
0,037  0,019  Retinoid X alpha receptor antagonist
0,129  0,110  MAP kinase 3 inhibitor
0,029  0,011  Acid ceramidase inhibitor
0,072  0,054  S-adenosyl-L-methionine decarboxylase inhibitor
0,049  0,031  Glucose-6-phosphate isomerase inhibitor
0,102  0,085  Topoisomerase II inhibitor
0,108  0,091  Cyclooxygenase 3 inhibitor
0,093  0,077  Carbonic anhydrase XV inhibitor
0,066  0,050  Glutamate (mGluR6) antagonist
0,038  0,023  Glutamate (mGluR3) antagonist
0,056  0,041  Xanthine dehydrogenase inhibitor
0,059  0,044  Potassium channel intermediate-conductance Ca-activated blocker
0,066  0,052  Exportin-1 inhibitor
0,029  0,016  Antibiotic Naphthyridine-like
0,069  0,057  Glycine receptor agonist
0,121  0,109  Antiviral (Herpes)
0,175  0,163  CYP2C19 substrate
0,050  0,038  Anesthetic inhalation
0,107  0,095  Contraceptive female
0,020  0,008  Vesicular glutamate transport inhibitor
0,063  0,051  Acetylcholine M5 receptor agonist
0,048  0,037  Nicotinic receptor alpha4 subunit antagonist
0,037  0,026  5-Alpha-reductase inhibitor
0,116  0,104  Psychosexual dysfunction treatment
0,139  0,128  Antiviral (Influenza)
0,100  0,089  Photosensitizer
0,122  0,111  Heat shock protein 90 antagonist
0,086  0,075  MAO A inhibitor
0,037  0,027  Glutamate (mGluR8) agonist
0,024  0,014  Retinoid X gamma receptor agonist
0,041  0,031  Guanylate cyclase inhibitor
0,039  0,030  CF transmembrane conductance regulator antagonist
0,033  0,024  Sodium-dependent vitamin C transporter 2 inhibitor
0,101  0,093  Interleukin 8 antagonist
0,086  0,078  Xanthine oxidase inhibitor
0,041  0,034  Nicotinic receptor alpha3 subunit antagonist
0,136  0,128  Antineoplastic (gastric cancer)
0,092  0,084  UGT2B1 substrate
0,086  0,079  Lanosterol 14 alpha demethylase inhibitor
0,064  0,057  MDM2 inhibitor
0,028  0,021  Nicotinic alpha4beta2 receptor agonist
0,154  0,147  Antiviral (HIV)
0,136  0,129  Antihelmintic
0,033  0,026  Fumarate hydratase inhibitor
0,074  0,067  Glycine receptor antagonist
0,050  0,043  Acetylcholine muscarinic agonist
0,050  0,044  GABA receptor antagonist
0,063  0,057  Endocannabinoid uptake inhibitor
0,068  0,062  Adenosine A3 receptor antagonist
0,160  0,154  Antiviral (Ebola)
0,026  0,020  Nicotinic acid receptor 2 antagonist
0,026  0,021  Uridine phosphorylase inhibitor
0,082  0,076  Paget's disease treatment
0,070  0,065  Vanilloid 4 agonist
0,010  0,005  Antibiotic beta Lactam-like
0,026  0,022  LFA antagonist
0,020  0,016  Retinoid X beta receptor antagonist
0,070  0,066  Macrophage migration inhibitory factor inhibitor
0,072  0,068  Acetylcholine nicotinic agonist
0,020  0,017  Lysophosphatidic acid 1 receptor antagonist
0,055  0,052  Potassium channel (Ca-activated) blocker
0,086  0,083  Bile acid receptor antagonist
0,016  0,014  Nicotinic acid receptor 1 antagonist
0,026  0,024  Glucosylceramidase stimulant
0,049  0,047  Alpha-mannosidase inhibitor
0,037  0,035  Acetylcholine M1 receptor agonist
0,004  0,003  Antibiotic Carbapenem-like
0,180  0,178  Hypoxia-inducible factor 1 alpha inhibitor
0,052  0,051  Cyclin-dependent kinase 6 inhibitor
0,055  0,054  Phosphodiesterase 1A inhibitor
0,043  0,041  Aldosterone antagonist
0,012  0,011  Angiotensin AT1B receptor antagonist
0,081  0,080  Thioredoxin inhibitor
0,065  0,064  Phospholipase D inhibitor
0,039  0,038  Oleamide hydrolase inhibitor
0,018  0,017  Kainate receptor 1 antagonist
0,040  0,040  Antimetabolite
0,018  0,017  Hexokinase stimulant
0,030  0,030  Retinoid X alpha receptor agonist
0,084  0,084  Carbonic anhydrase III inhibitor

